Bio-Techne (TECH) Reports Q3 2026 Earnings with Revenue Decline and Adjusted EPS Drop
Bio-Techne (TECH) reported Q3 2026 earnings with total revenue of $311.4 million, a 2% decline on an organic and reported basis. Adjusted EPS fell to $0.53, down $0.03 from the prior year. The company noted a 34.2% adjusted operating margin, a sequential improvement but a 70 basis point decline year-over-year.
Tickers: $TECH
Topics: adjusted_eps adjusted_operating_margin biotech cash_flow earnings organic_growth pharma revenue